Bioavailability and foam cells permeability enhancement of Salvianolic acid B pellets based on drug-phospholipids complex technique

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 83, Issue 1, 2013, Pages 76-86

  Li, Jin ^a,b   Liu, Pan ^b   Liu, Jian Ping ^b   Yang, Ji Kun ^b   Zhang, Wen Li ^b   Fan, Yong Qing ^b   Kan, Shu Ling ^b   Cui, Yan ^b   Zhang, Wen Jing ^b  

^a XUZHOU MEDICAL UNIVERSITY   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Extrusion spheronization; Foam cells; Pellets; Permeability; Phospholipids complex; Water soluble drug

Indexed keywords

PHOSPHOLIPID; SALVIANOLIC ACID B;

ANIMAL CELL; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CELL MEMBRANE PERMEABILITY; COMPLEX FORMATION; CRUSHING STRENGTH; DIFFERENTIAL SCANNING CALORIMETRY; DRUG BIOAVAILABILITY; DRUG PELLET; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; EXPERIMENTAL RABBIT; FOAM CELL; HYDRATION; IN VIVO STUDY; MALE; MAXIMUM PLASMA CONCENTRATION; MOUSE; NONHUMAN; PARTITION COEFFICIENT; PELLET EXTRUSION; SCANNING ELECTRON MICROSCOPY; SPHERONIZATION; TENSILE STRENGTH; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; AREA UNDER CURVE; BENZOFURANS; BIOLOGICAL AVAILABILITY; CALORIMETRY, DIFFERENTIAL SCANNING; CELLULOSE; EXCIPIENTS; FOAM CELLS; LACTOSE; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; PARTICLE SIZE; PERMEABILITY; PHOSPHOLIPIDS; POVIDONE; RABBITS; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TIME FACTORS;

EID: 84871927946     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2012.09.021     Document Type: Article

References (30)

1. T. Shimaoka, N. Kume, M. Minami, K. Hayashida, H. Kataoka, T. Kita, and S. Yonehara Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages J. Biol. Chem. 275 2000 40663
2. Y. Fu, L. Maianu, B.R. Melbert, and W.T. Garvey Facilitative glucose transporter gene expression in human lymphocytes, monocytes, and macrophages: a role for GLUT isoforms 1, 3, and 5 in the immune response and foam cell formation Blood Cell Mol. Dis. 32 2004 182 190
3. P.Y. Yang, and Y.C. Rui Intercellular adhesion molecule-1 and vascular endothelial growth factor expression kinetics in macrophage-derived foam cells Life Sci. 74 2003 471 480
4. Y.T. Wu, Y.F. Chen, Y.J. Hsieh, I. Jaw, M.S. Shiao, and T.H. Tsai Bioavailability of salvianolic acid B in conscious and freely moving rats Int. J. Pharm. 326 2006 25 31
5. O. Karmin, E.G. Lynn, R. Vazhappilly, K.K.W. Au-Yeung, D.Y. Zhu, and Y.L. Siow Magnesium tanshinoate B (MTB) inhibits low density lipoprotein oxidation Life Sci. 68 2001 903 912
6. B. Jiang, W. Wu, M. Li, L. Xu, K. Sun, M. Yang, S. Guan, X. Liu, and D. Guo Cardioprotection and matrix metalloproteinase-9 regulation of salvianolic acids on myocardial infarction in rats Planta Med. 75 2009 1286 1292
7. J.Y. Han, J.Y. Fan, Y. Horie, S. Miura, D.H. Cui, H. Ishii, T. Hibi, H. Tsuneki, and I. Kimura Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion Pharm. Therapeut. 117 2008 280 295
8. L. Zhou, M.S.S. Chow, and Z. Zuo Effect of sodium caprate on the oral absorptions of danshensu and salvianolic acid B Int. J. Pharm. 379 2009 109 118
9. R. Panchagnula, and N.S. Thomas Biopharmaceutics and pharmacokinetics in drug research Int. J. Pharm. 201 2000 131 150
10. A. Semalty, M. Semalty, M.S.M. Rawat, and F. Franceschi Supramolecular phospholipids-polyphenolics interactions: the PHYTOSOME® strategy to improve the bioavailability of phytochemicals Fitoterapia 81 2010 306 314
11. S. Nazzal, I. Smalyukh, O. Lavrentovich, and M.A. Khan Preparation and in vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion formation Int. J. Pharm. 235 2002 247 265
12. F. Cui, K. Shi, L. Zhang, A. Tao, and Y. Kawashima Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation J. Control. Release 114 2006 242 250
13. Y. Lu, Y. Zhang, Z. Yang, and X. Tang Formulation of an intravenous emulsion loaded with a clarithromycin-phospholipid complex and its pharmacokinetics in rats Int. J. Pharm. 366 2009 160 169
14. T. Gershanik, and S. Benita Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs Eur. J. Pharm. Biopharm. 50 2000 179 188
15. A. Abdalla, and K. Mader Preparation and characterization of a self-emulsifying pellet formulation Eur. J. Pharm. Biopharm. 66 2007 220 226
16. S. Xie, Y.F. Lee, E. Kim, L.M. Chen, J. Ni, L.Y. Fang, S. Liu, S.J. Lin, J. Abe, and B. Berk TR4 nuclear receptor functions as a fatty acid sensor to modulate CD36 expression and foam cell formation Proc. Natl. Acad. Sci. 106 2009 13353 13358
17. E. Atef, and A.A. Belmonte Formulation and in vitro and in vivo characterization of a phenytoin self-emulsifying drug delivery system (SEDDS) Eur. J. Pharm. Biopharm. 35 2008 257 263
18. Y. Zhang, M. Huo, J. Zhou, and S. Xie PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel Comput. Meth. Prog. Biol. 99 2010 306 314
19. J. Wu, D. Chen, and Y. Liu Study on the preparation of baicalin complex with phospholipid Chin. J. Chin. Mater. Med. 26 2001 166 169
20. K. Maiti, K. Mukherjee, A. Gantait, B.P. Saha, and P.K. Mukherjee Curcumin-phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats Int. J. Pharm. 330 2007 155 163
21. X. Yanyu, S. Yunmei, C. Zhipeng, and P. Qineng The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats Int. J. Pharm. 307 2006 77 82
22. J. Ruan, J. Liu, D. Zhu, T. Gong, F. Yang, X. Hao, and Z. Zhang Preparation and evaluation of self-nanoemulsified drug delivery systems (SNEDDSs) of matrine based on drug-phospholipid complex technique Int. J. Pharm. 386 2010 282 290
23. F.R. Venema, and W.D. Weringa The interactions of phospholipid vesicles with some anti-inflammatory agents J. Colloid Interf. Sci. 125 1988 484 492
24. E. Lasonder, and W.D. Weringa An NMR and DSC study of the interaction of phospholipid vesicles with some anti-inflammatory agents J. Colloid Interf. Sci. 139 1990 469 478
25. J. Hüsch, B. Dutagaci, C. Glaubitz, T. Geppert, G. Schneider, M. Harms, C. Müller-Goymann, L. Fink, M.U. Schmidt, and C. Setzer Structural properties of the so-called NSAID-phospholipid-complexes Eur. J. Pharm. Sci. 44 2011 103 116
26. P.F. Yue, H.L. Yuan, X.Y. Li, M. Yang, and W.F. Zhu Process optimization, characterization and evaluation in vivo of oxymatrine-phospholipid complex Int. J. Pharm. 387 2010 139 146
27. P. Kleinebudde The crystallite-gel-model for microcrystalline cellulose in wet-granulation, extrusion, and spheronization Pharm. Res. 14 1997 804 809
28. V. Sinha, M. Agrawal, and R. Kumria Influence of formulation and excipient variables on the pellet properties prepared by extrusion spheronization Curr. Drug Deliv. 2 2005 1 8
29. E. Franceschinis, D. Voinovich, M. Grassi, B. Perissutti, J. Filipovic-Grcic, A. Martinac, and F. Meriani-Merlo Self-emulsifying pellets prepared by wet granulation in high-shear mixer: influence of formulation variables and preliminary study on the in vitro absorption Int. J. Pharm. 291 2005 87 97
30. G. Ye, S. Wang, P.W.S. Heng, L. Chen, and C. Wang Development and optimization of solid dispersion containing pellets of itraconazole prepared by high shear pelletization Int. J. Pharm. 337 2007 80 87